Newsroom | 6340 results

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing and commercializing novel therapeutics for debilitating neurodegenerative disorders, today announced that Michael McFadden, Chief Executive Officer, and Lauren D’Angelo, Chief Operating Officer, will participate in the upcoming investor events: Craig-Hallum Alpha Select Conference Format: 1x1 meetings Date: Tuesday, No...

MANHASSET, N.Y.--(BUSINESS WIRE)--Imagine a future where a serious, often-missed condition affecting older hospital patients could be predicted and prevented before it even starts. To help make that future a reality, researchers at Northwell Health’s Feinstein Institutes for Medical Research have been awarded a $3.4-million grant from the National Institutes of Health (NIH) to develop cutting-edge artificial intelligence (AI) tools to detect and prevent delirium – a significant risk factor for...

DUBLIN--(BUSINESS WIRE)--Prothena today reported financial results for the third quarter and first nine months of 2026 and provided business highlights....

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 2,010 shares of the Company’s common stock to one new employee (the “Inducement Grant”) on November 3, 2026 (the “Grant Date”). The Induceme...

SAN FRANCISCO--(BUSINESS WIRE)--Pharos is a Compatible Vendor for the American Heart Association's Get With The Guidelines® - Stroke program, the largest hospital-based stroke quality improvement registry in the United States. The designation lets participating hospitals use Pharos to abstract and submit chart data directly to Get With The Guidelines - Stroke. More than 2,600 U.S. hospitals participate in Get With The Guidelines - Stroke, covering the majority of stroke admissions nationwide. F...

DALLAS--(BUSINESS WIRE)--ProCare Injury Specialists announced plans to open three new clinics in Garland, North Dallas, and Mesquite in the coming months....

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that updated data from a Phase 1b/2 trial of zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC), will be shared tomorrow at the North American Neuroendocrine Tumor Society (NANETS) 2026 Multidisciplinary NET Medical Symposium in Las Vegas. The data indicate that zoci demonstrated clinically meaningf...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing...

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced plans to present data from across its psychiatry and sleep medicine portfolios at the Neuroscience Education Institute (NEI) Fall Congress, taking place Nov. 5-8, 2026 in Colorado Springs, Colo. The company will present data related to LYBALVI® (olanzapine and samidorphan), ARISTADA® (aripiprazole lauroxil) and LUMRYZ® (sodium oxybate) extended-release oral suspension, as well as alixorexton, the company’s novel, investigation...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the third quarter ended September 30, 2026. “Acadia delivered a strong third quarter, with total revenues of $342 million and continued commercial momentum across DAYBUE and NUPLAZID,” said Catherine Owen Adams, Chief Executive Officer of Acadia. “In the U.S., DAYBUE delivered another strong quarter, supported by meaningful uptake of DAYBUE STIX. In Europe, we are excited to build m...